Related Experiment Videos
Inflammatory myofibroblastic tumor: cytogenetic evidence supporting clonal origin
L D Su1, A Atayde-Perez, S Sheldon
1Department of Pathology, University of Michigan Hospitals, Ann Arbor 48105-0054, USA.
Summary
Inflammatory myofibroblastic tumors (IMTs) in children show clonal chromosomal abnormalities, suggesting they are neoplastic. These findings support IMTs as a distinct neoplastic proliferation requiring further study.
Area of Science:
- Oncology
- Cytogenetics
- Pediatric Pathology
Background:
- Inflammatory myofibroblastic tumor (IMT) is a controversial lesion in children, characterized by myofibroblastic cells and inflammatory infiltrate.
- Previously termed plasma cell granuloma or inflammatory pseudotumor, its neoplastic potential has been debated.
- Limited cytogenetic data exists for IMTs, hindering understanding of their pathogenesis.
Observation:
- Karyotype analyses were performed on three pediatric IMTs: pulmonary, mesenteric, and retroperitoneal.
- A pulmonary IMT exhibited an abnormal karyotype with a ring chromosome 8.
- Mesenteric and retroperitoneal IMTs displayed complex clonal chromosomal aberrations.
Findings:
- All three studied IMTs demonstrated clonal chromosomal aberrations.
- These genetic anomalies provide strong evidence for the neoplastic nature of IMTs.
- The specific aberrations varied between the tumors, indicating potential heterogeneity.
Implications:
- The findings support the classification of IMT as a neoplastic proliferation rather than a reactive process.
- This has significant implications for diagnosis, prognosis, and potential therapeutic strategies.
- Further research into IMT cytogenetics is warranted to elucidate specific driver mutations and refine classification.